by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Grace Nguyen, PharmD, BCPS, provides real-world experiences with DPYD genotype-guided fluoropyrimidine dosing, highlighting how pharmacist-led interventions and tailored dose adjustments can help mitigate toxicity risks and optimize...
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Derek Webb, PharmD, a community pharmacist and Virginia Board of Pharmacy member, provides comprehensive guidance on managing seasonal allergies, distinguishing between symptoms, and exploring treatment options for patients. Read...
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Integrated health system specialty pharmacies can improve patient care for non–multiple sclerosis neurologic conditions. Read More
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Real change often begins within pharmacies. Read More
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles Pharmacists have an evolving role in biotechnology. Read More
by MM360 Staff | May 28, 2025 | Myeloma News
Source: Pharmacy Times articles A new biosimilar to ustekinumab (Stelara) has been approved by the FDA, further expanding treatment options for patients with immune conditions such as plaque psoriasis and psoriatic arthritis. Read More
